Filing Details
- Accession Number:
- 0000911916-17-000044
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2017-02-06 16:22:31
- Reporting Period:
- 2017-02-02
- Filing Date:
- 2017-02-06
- Accepted Time:
- 2017-02-06 16:22:31
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1136869 | Zimmer Biomet Holdings Inc. | ZBH | Orthopedic, Prosthetic & Surgical Appliances & Supplies (3842) | 134151777 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1346672 | F Chad Phipps | C/O Zimmer, Inc. P. O. Box 708 Warsaw IN 46580 | Sr. Vp/Gen Counsel/Secretary | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2017-02-02 | 10,500 | $83.68 | 44,262 | No | 4 | M | Direct | |
Common Stock | Disposition | 2017-02-02 | 10,500 | $117.62 | 33,762 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | M | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Employee Stock Option (right to buy) | Disposition | 2017-02-02 | 10,500 | $0.00 | 10,500 | $83.68 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
0 | 2017-02-05 | No | 4 | M | Direct |
Footnotes
- Securities acquired or sold pursuant to a written plan intended to comply with Rule 10b5-1(c)(i) adopted by Mr. Phipps on August 16, 2016.
- Includes 169 shares acquired under the Zimmer Biomet Holdings, Inc. (the "Company") Employee Stock Purchase Plan between May 2, 2016 and January 30, 2017 and 249 shares purchased between April 29, 2016 andJanuary 27, 2017 under the dividend reinvestment plan for the Company's common stock.
- Represents the sale of 10,500 shares in multiple transactions, ranging in price from $117.32 to $117.90 per share, resulting in a weighted average sale price of $117.6172. The reporting person will provide, upon request by the SEC staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each price within the range.
- Vested annually over four years in increments of 25% each year, commencing on February 6, 2008.